Effects of perinatal loratadine exposure on male rat reproductive organ development

Reproductive Toxicology

Volumn 17, Issue 6, 2003, Pages 691-697

  McIntyre, Barry S ^a   Vancutsem, Paul M ^a,b   Treinen, Kimberley A ^a   Morrissey, Richard E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Anogenital distance; Fetal; Hypospadias; Loratadine; Nipple retention; Rat; Reproductive development

Indexed keywords

ANTIANDROGEN; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; METHYLCELLULOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; AUTOPSY; BODY WEIGHT; CONTROLLED STUDY; DRUG EXPOSURE; EUTHANASIA; FEMALE; GENITAL SYSTEM; IN VIVO STUDY; MALE; NIPPLE; NONHUMAN; ORGANOGENESIS; PERINATAL PERIOD; PREGNANCY; PREPUTIAL GLAND; PROGENY; PROSTATE; RAT; RAT STRAIN; SEMINAL VESICLE;

EID: 0344876447     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(03)00108-4     Document Type: Article

References (32)

1. PDR Electronic Library™ Online: Claritin™. Thomson MICROMEDEX, 2002-2003.
2. Summary basis of approval for loratadine (Claritin™). Pharmacology/toxicology review of NDA submission. Schering Corporation, April 12, 1993.
3. Hassan AB, Ayoub MM, Godhaim REM, Youssef HI, Eid MA. Studies on the effect of some antihistamines on the reproductive organs of male rats. Vet Med J 1983;31(2):277-86.
4. Kallen B, Olausson PO. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Saf Med 2001;14:115-9.
5. Schardein J. Hormones and hormone antagonists. New York: Marcel Dekker; 1993.
6. Berman DM, Tian H, Russell DW. Expression and regulation of steroid 5 alpha-reductase in the urogenital tract of the fetal rat. Mol Endocrinol 1995;9:1561-70.
7. Clark RL, Anderson CA, Prahalada S, Robertson RT, Lochry EA, Leonard YM, et al. Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5 alpha-reductase inhibitor. Toxicol Appl Pharmacol 1993;119:34-40.
8. Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaughan ED. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 1999;131(3):1149-56.
9. Kassim NM, McDonald SW, Reid O, Bennett NK, Gilmore DP, Payne AP. The effects of pre- and postnatal exposure to the nonsteroidal antiandrogen flutamide on testis descent and morphology in the Albino Swiss rat. J Anat 1997;190:577-88.
10. Roy AK, Chatterjee B. Androgen action. Crit Rev Eukaryot Gene Expr 1995;5:157-76.
11. Silversides DW, Price CA, Cooke GM. Effects of short-term exposure to hydroxyflutamide in utero on the development of the reproductive tract in male mice. Can J Physiol Pharmacol 1995;73:1582-8.
12. Veyssiere G, Berger M, Jean-Faucher C, de Turckheim M, Jean C. Testosterone and dihydrotestosterone in sexual ducts and genital tubercle of rabbit fetuses during sexual organogenesis: effects of fetal decapitation. J Steroid Biochem 1982;17:149-54.
13. Wilson JD, Lasnitski I. Dihydrotestosterone formation in fetal tissues of the rabbit and rat. Endocrinology 1971;89:659-68.
14. Kratochwil K. Tissue combination and organ culture studies in the development of the embryonic mammary gland. Dev Biol 1986;4:315-33.
15. Kratochwil K, Schwartz P. Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosterone. Proc Natl Acad Sci USA 1976;73:4041-4.
16. Imperato-McGinley J, Binienda Z, Gedney J, Vaughan Jr ED. Nipple differentiation in fetal male rats treated with an inhibitor of the enzyme 5 alpha-reductase: definition of a selective role for dihydrotestosterone. Endocrinology 1986;118:132-7.
17. Kratochwil K. Development and loss of androgen responsiveness in the embryonic rudiment of the mouse mammary gland. Dev Biol 1977;61:358-65.
18. Daston G, Kimmel C, editors. An evaluation and interpretation of reproductive endpoints for human health risk assessment. International Life Sciences Institute Health and Environmental Sciences Institute Developmental and Reproductive toxicology Committee; 1998.
19. Mylchreest E, Sar M, Cattley RC, Foster PM. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol 1999;156:81-95.
20. Gray Jr LE, Wolf C, Lambright C, Mann P, Price M, Cooper RL, et al. Administration of potentiallyantiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 1999;15:94-118.
21. Gray Jr LE, Ostby JS, Kelce WR. Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmcol 1994;129:46-52.
22. McIntyre BS, Barlow NJ, Wallace DG, Maness SC, Gaido KW, Foster PM. Effects of in utero exposure to linuron on androgen-dependent reproductive development in the male Cr1:CD(SD)BR rat. Toxicol Appl Pharmacol 2000;167:87-99.
23. McIntyre BS, Barlow NJ, Foster PM. Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci 2001;62(2):236-49.
24. Mylchreest E, Cattley RC, Foster PM. Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: an antiandrogenic mechanism? Toxicol Sci 1998;43:47-60.
25. You L, Casanova M, Archibeque-Engle S, Sar M, Fan LQ, Heck HA. Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p′-DDE. Toxicol Sci 1998;45:162-73.
26. Clark RL, Antonello JM, Grossman SJ, Wise LD, Anderson C, Bagdon WJ, et al. External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor. Teratology 1990;42:91-100.
27. Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh) 1980;95:540-5.
28. McIntyre BS, Barlow NJ, Foster PM. Male rats exposed to linuron in utero exhibit permanent changes in anogenital distance, nipple retention, and epididymal malformations that result in subsequent testicular atrophy. Toxicol Sci 2002;65(1):62-70.
29. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray Jr LE. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health 1999;15:80-93.
30. Elswick BA, Welsch F, Janszen DB. Effect of different sampling designs on outcome of endocrine disruptor studies. Reprod Toxicol 2000;14(4):359-67.
31. Baskin LS, Himes K, Colborn T. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect 2001;109: 1175-83.
32. U.S. EPA. EDSTAC final report: 1998.